Anil K. Sood

16 ta ish

The University of Texas MD Anderson Cancer Center

1. Circular RNAs in Cancer

   Duc‐Hiep Bach, Sang Kook Lee, Anil K. Sood

   Sharh maqolaOAOchiq kirish20193 iqtibos

   ABIABI:AkademIndex/2026.other.231087

2. Advances and Challenges of Liposome Assisted Drug Delivery

   Lisa Sercombe, Tejaswi Veerati, Fatemeh Moheimani +3

   Sharh maqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.250655

3. RNA interference-based therapy and its delivery systems

   Xiuhui Chen, Lingegowda S. Mangala, Cristian Rodriguez‐Aguayo +3

   Sharh maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.298078

4. Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

   William M. Merritt, Yvonne G. Lin, Liz Y. Han +19

   Maqola20083 iqtibos

   ABIABI:AkademIndex/2026.other.332248

5. Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor

   Anindya Das, Simone Pisana, Banani Chakraborty +8

   Maqola20083 iqtibos

   ABIABI:AkademIndex/2026.other.393802

6. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

   Monika Haemmerle, Morgan Taylor, Tony Gutschner +23

   MaqolaOAOchiq kirish20172 iqtibos

   ABIABI:AkademIndex/2026.other.131320

7. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer

   Marc D. Bullock, Andreia Silva, Pinar Kanlikilicer-Unaldi +5

   Sharh maqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.247207

8. Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

   Takemi Tanaka, Lingegowda S. Mangala, Pablo E. Vivas‐Mejía +18

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.704261

9. Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma

   Jee Young Hwang, Lingegowda S. Mangala, Jansina Y. Fok +11

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.704264

10. Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer

    Charles N. Landen, Blake W. Goodman, Ashwini A. Katre +11

    Maqola20102 iqtibos

    ABIABI:AkademIndex/2026.other.704268

11. Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer

    Charles N. Landen, William M. Merritt, Lingegowda S. Mangala +11

    Maqola20062 iqtibos

    ABIABI:AkademIndex/2026.other.704278

12. c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer

    Pablo E. Vivas‐Mejía, Juliana M. Benito, Ariel Fernández +16

    Maqola20092 iqtibos

    ABIABI:AkademIndex/2026.other.704292

13. Therapeutic Targeting of ATP7B in Ovarian Carcinoma

    Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt +18

    Maqola20092 iqtibos

    ABIABI:AkademIndex/2026.other.704298

14. Integrated genomic analyses of ovarian carcinoma

    Debra Bell, Andrew Berchuck, Michael J. Birrer +94

    Maqola20112 iqtibos

    ABIABI:AkademIndex/2026.other.769688

15. Data from Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

    Pablo E. Vivas‐Mejía, Cristian Rodriguez-Aguayo, Hee-Dong Han +6

    PreprintOAOchiq kirishRNA Interference and Gene Delivery20230 iqtibos

    ABIABI:AkademIndex/2023.preprint.000098

16. Data from Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

    Pablo E. Vivas‐Mejía, Cristian Rodriguez-Aguayo, Hee-Dong Han +6

    PreprintOAOchiq kirishRNA Interference and Gene Delivery20230 iqtibos

    ABIABI:AkademIndex/2023.preprint.000099